UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 9, 2021
Accession Number:
Submission Type:
CIK: 0001537561
Company Name: Arch Therapeutics, Inc.
File Number: 333-253588